Clinical Trials Directory

Trials / Unknown

UnknownNCT03789409

Intermittent Fasting Following Acute Ischemic Stroke

Intermittent Fasting Following Acute Ischemic Stroke: Prospective, Randomized, Parallel Group, Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
Ulsan University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Despite numerous kinds of evidence on functional health and CNS protection of intermittent fasting after injuries were found in many brain-, and spinal cord-damaged animal models, there has yet to be any clinical study of intermittent fasting after acute ischemic cerebral infarction. The aim of this study is to evaluate the neurological, functional and clinical efficacy of intermittent fasting in patients after acute ischemic stroke.

Detailed description

In order to verify the validity and clinical efficacy of intermittent fasting for neurological and functional effects of ischemic cerebral infarction, the first ischemic stroke (diagnosed within 1 year through brain MRI / CT) patients will be randomly assigned to intermittent fasting group or control group. In both groups, physical therapy, occupational therapy and speech therapy will be provided during 3 hours in total a day. The intermittent fasting group should maintain intermittent fasting for no less than 12 hours or more every day during the rehabilitation period (at least 1 week), and the control group is able to eat all of the hospital meals and all the participants want without any time limit. The efficacy of intermittent fasting is to be verified by performing the electro-physiological tests and functional evaluations before participation, 1st week, 2nd weeks after participation, before discharge, 3 months, and 6 months after the stroke onset.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTIntermittent FastingThe aforementioned intermittent fasting in arm/group descriptions.

Timeline

Start date
2019-03-04
Primary completion
2021-01-31
Completion
2021-01-31
First posted
2018-12-28
Last updated
2019-12-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03789409. Inclusion in this directory is not an endorsement.